Current status and future prospects of percutaneous treatment of mitral valve disease: repair vs. replacement

Manel Sabaté

Vessel Plus ›› 2022, Vol. 6 ›› Issue (1) : 27

PDF
Vessel Plus ›› 2022, Vol. 6 ›› Issue (1) :27 DOI: 10.20517/2574-1209.2021.135
Editorial

Current status and future prospects of percutaneous treatment of mitral valve disease: repair vs. replacement

Author information +
History +
PDF

Cite this article

Download citation ▾
Manel Sabaté. Current status and future prospects of percutaneous treatment of mitral valve disease: repair vs. replacement. Vessel Plus, 2022, 6(1): 27 DOI:10.20517/2574-1209.2021.135

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Cepas-Guillen PL,Regueiro A.Percutaneous treatment of mitral valve disease: repair vs. replacement.Vessel Plus2021;5:2

[2]

Scotti A,Margonato A.Patient selection for trans-catheter mitral valve repair vs. replacement: ongoing indications and glimpse to the future.Vessel Plus2021;5:6

[3]

Spieker M,Spießhoefer J.Percutaneous mitral valve repair with the MitraClip in patients with handgrip exercise-induced dynamic mitral regurgitation.Vessel Plus2020;4:29

[4]

Echarte-Morales J,Benito-González T.Percutaneous treatment of mitral regurgitation recurrence after mitral valve surgery.Vessel Plus2021;5:54

[5]

Nappi F,Singh SSA.Transcatheter valve-in-valve implantation vs. reoperative mitral valve surgery for failing surgical prosthesis.Vessel Plus2021;5:40

PDF

29

Accesses

0

Citation

Detail

Sections
Recommended

/